Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study

Clicks: 162
ID: 110808
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Key Points. Early introduction of cyclosporine did not improve HLH outcome in patients treated with the HLH-94 etoposide-dexamethasone backbone (P = .06).HLH-2
Reference Key
elisabet2017bloodconfirmed Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bergsten, Elisabet;Horne, AnnaCarin;Aricó, Maurizio;Astigarraga, Itziar;Egeler, R. Maarten;Filipovich, Alexandra H.;Ishii, Eiichi;Janka, Gritta;Ladisch, Stephan;Lehmberg, Kai;McClain, Kenneth L.;Minkov, Milen;Montgomery, Scott;Nanduri, Vasanta;Rosso, Diego;Henter, Jan-Inge;
Journal Blood
Year 2017
DOI
10.1182/blood-2017-06-788349
URL
http://dx.doi.org/10.1182/blood-2017-06-788349
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't female male Infant lymphohistiocytosis longitudinal studies hemophagocytic / mortality* hematopoietic stem cell transplantation / mortality cyclosporine / therapeutic use etoposide / therapeutic use* dexamethasone / therapeutic use* hemophagocytic / drug therapy* jan-inge henter annacarin horne pmid:28935695 pmc5785801 doi:10.1182/blood-2017-06-788349 elisabet bergsten antineoplastic combined chemotherapy protocols / therapeutic use hematopoietic stem cell transplantation / methods

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.